|
HS Code |
484467 |
| generic_name | Ketotifen |
| brand_name | Ketotifenum |
| drug_class | Antihistamine |
| formulation | Tablet |
| strength | 1 mg |
| route_of_administration | Oral |
| indication | Allergic conditions (such as asthma, allergic rhinitis) |
| mechanism_of_action | Mast cell stabilizer and histamine H1 receptor antagonist |
| contraindications | Hypersensitivity to ketotifen or excipients |
| common_side_effects | Drowsiness, dry mouth, weight gain |
| pregnancy_category | C |
| storage_conditions | Store below 25°C, protect from light and moisture |
| prescription_status | Prescription only |
| manufacturer | Varies by region |
| ATC_code | R06AX17 |
As an accredited Ketotifenum factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | The packaging for Ketotifenum features a white box, blue accents, and contains 30 tablets, each with 1 mg of active ingredient. |
| Shipping | **Ketotifenum** should be shipped in tightly sealed, chemical-resistant containers, compliant with local and international regulations. During transportation, protect from light, moisture, and extreme temperatures. Label packages with appropriate hazard warnings. Handle carefully to prevent breakage and spills. Ensure shipping documentation includes safety data sheets and emergency procedures. |
| Storage | **Ketotifenum** should be stored in a tightly closed container, protected from light and moisture. Keep it at room temperature, ideally between 15°C and 30°C (59°F–86°F), in a well-ventilated, dry area away from incompatible substances. Ensure storage in a designated chemical storage area, clearly labeled, and out of reach of unauthorized personnel, children, and pets. |
Applications of Ketotifenum in Industrial ManufacturingAs a dedicated manufacturer of Ketotifenum, we supply this raw material to a variety of industries where strict regulation, precise formulation, and specialized processing define downstream integration. Below, we outline the primary industrial applications, compliance requirements, technical usage parameters, and key processed end products for Ketotifenum. 1. Pharmaceutical Antiallergic FormulationsPharmaceutical companies utilize Ketotifenum as an active pharmaceutical ingredient in the development of oral and topical anti-allergic medications. Manufacturers conduct phase-specific formulation under controlled environments, incorporating Ketotifenum for its non-sedating antihistaminic properties. Each batch undergoes validation according to pharmacopeial standards, with attention to residual solvents, assay, and trace impurity profiles. Preparation involves precise granulation or suspension methods, followed by tablet compression, ointment mixing, or syrup blending for chronic allergy management products. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Ophthalmic Drug ManufacturingOphthalmic manufacturers implement Ketotifenum for sterile eye drop production targeted at acute and chronic allergic conjunctivitis treatment. Operators dissolve and filter the raw material in aqueous, buffered vehicles under aseptic conditions, applying advanced sterilization protocols to meet stringent regulatory benchmarks. Formulation engineering focuses on isotonicity, pH adjustment, and preservation during scale-up to ensure product safety and comfort at the ocular surface. Final vials undergo batch-by-batch microbiological and particle testing before market release. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Active Ingredient for Veterinary PharmaceuticalsVeterinary drug manufacturers formulate Ketotifenum into oral and injectable products for companion animal use, particularly for managing allergic bronchitis and atopic conditions in dogs, cats, and horses. Manufacturing lines blend the ingredient into palatable suspensions or sterile injectable solutions, following animal health regulatory frameworks. Quality teams verify identity, potency, and residue limits through HPLC and validated bioassays. Manufacturers scale formulations in accordance with species weight, anticipated metabolism, and target dosing compliance. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Research Chemical Supply for Drug Discovery and Preclinical StudiesContract research organizations and pharmaceutical R&D laboratories use precise grades of Ketotifenum in preclinical screening, in vitro pharmacology, and pharmacokinetic studies. The compound serves as a reference standard in cell culture assays and animal models for mechanistic research into mast cell stabilization and antihistaminic pathways. Supplied materials meet analytical reference standards with traceable certificates of analysis, purity profiling, and residual solvent validation to ensure study reproducibility and data integrity. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
5. Contract Manufacturing for Generic Finished Dosage FormsGeneric pharmaceutical CDMOs use Ketotifenum during the large-scale manufacturing of authorized generic anti-allergy therapies, including replicating branded reference formulations for global export. Facilities employ controlled granulation, tablet press calibration, and validated coating machines to produce uniform and bioequivalent final products. Documentation for every lot aligns with ANDA submission dossiers and respective country-specific monograph standards, ensuring all in-process and finished batch specifications are met and fully traceable. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive Ketotifenum prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Manufacturing Ketotifenum takes a focused approach, and our facility has spent years refining the process that brings this crucial active ingredient to the global market. As the team handling each stage — from synthesis to packaging — we've learned a lot about the science behind this compound and the practical expectations of formulators and downstream users. For anyone formulating allergy relief medicines, topical anti-itch preparations, or working to meet strict pharmacopoeia requirements, understanding a molecule’s origins and unique properties lays the groundwork for consistent quality in the finished dose.
We produce Ketotifenum as a pure, crystalline substance intended primarily for pharmaceutical use, with a model that aligns with the molecular structure C19H19NO3S. Quality goes beyond purity on paper. Our most recent production runs consistently achieve an assay of over 99.5% (on dried basis). For several years, the fight has been to not just hit the minimum standard but to make the product easier for downstream tablet manufacturers and compounding pharmacists. One real-world challenge is how trace residual solvents or color impurities can cause headaches later in the pipeline. Meeting — and often exceeding — the specifications listed in the European Pharmacopeia and United States Pharmacopeia has come from fine-tuning solvent control and recrystallization protocols.
By steering away from unnecessarily complex additive systems, we’ve created a product that dissolves quickly in the manufacturing medium, yielding clear and stable solutions for further processing. This attribute comes directly from in-house optimization. Unlike many generic options that rely on less stringent purification steps, our material stands up to scrutiny during both small-scale laboratory analysis and full-scale production validation, leading to ease during blending and tableting.
Formulators rely on Ketotifenum as a non-corticosteroid solution to address allergic conjunctivitis and certain types of rhinitis. Our customers — including mid-size generic drug producers, hospital compounding centers, and research institutions — consistently express the need for predictable reaction profiles and stability. They work across oral, topical, and ophthalmic preparations. From our vantage point, reproducibility is not just a buzzword. Each batch is torqued toward meeting rigid photostability standards, ensuring that drops or tablets hold up during shipping, at point-of-care dispensing, or even in regions where ambient temperatures fluctuate.
A large share of requests we fill are for fine, needle-shaped crystals with consistent bulk density, as this makes blending into oral tablets more efficient and cuts down on loss during handling. The same goes for powders milled to pass through a 60-mesh sieve for solution preparations. Many partners have shared their challenges with lump formation when working with off-brand material from traders or secondary processors. Fine-tuning particle morphology has been a multi-year initiative for our process engineers, who spend years mastering equipment parameters and process flow.
Manufacturing Ketotifenum brings unique challenges. Take water control for example: during certain reaction steps, even a trace of moisture can cause unwanted byproducts or color formation. Controlling this comes down to real-world details, like maintaining overpressure with dry nitrogen and revalidating drier integrity after each maintenance cycle. Equipment cleaning, especially for glass-lined reactors, matters more than just ticking a box on a checklist; old residues from previous runs can catalyze unexpected reactions, especially when dealing with sensitive aromatic substitution steps. Investing in stainless steel upgrades and single-use transfer lines solved cross-batch contamination issues after several years of battling these in our own suites.
For a long time, industry guidelines set by pharmacopeias gave little practical guidance about actual manufacturing variability from one site to another. Collaborating with formulation partners led to process bulletins and detailed reviews with their QA teams, which in turn led us to adjust everything from cGMP documentation practices to storage stability protocols. Each small improvement compounds into more reliable release profiles in end-user laboratories — which we've seen ourselves when testing retained samples against newer lots.
Over the years, we've heard firsthand about the pitfalls users face when sourcing from resellers or brokers who offer inconsistent lots. One year, we analyzed several competitor samples and found unexplained color tints and high peroxide values — both signal stability issues down the line. This is a direct consequence of aging stocks and improper storage. For our product, we run ongoing trend analysis of impurity profiles. Any deviation, even if within regulatory limits, prompts a root-cause review by our QA team. As a result, our partners report fewer instances of failed dissolution tests and avoided loss of finished goods, which saves time and money at multiple stages.
From a practical standpoint, many alternative sources cut corners on particle size control, leading to problems during blending or inhomogeneous mixing. Several customers have replaced less reliable sources with our Ketotifenum following field complaints about gritty suspensions in eye drops or tablets that failed content uniformity. While some labs attempt to reprocess and re-mill off-grade material, our experience shows that consistent morphology from the outset drives manufacturing efficiency and reduces waste.
Sourcing directly from our facility provides another advantage — block chain of custody and traceable batch records. Intermediary suppliers sometimes lose sight of full documentation, while our partners have access to detailed certificates, validated transportation protocols, and unique batch-level analytics that have stood the test under international regulatory inspection.
Longer term customers stay with us because of the reliability we bring — not simply because of a price point, but because it makes their own manufacturing or compounding predictable. During a decade working in this industry, feedback loops with downstream product developers and healthcare professionals have shaped the details of our QC methodology. It’s not about generic checklists. Each product release ties back to deeper hands-on involvement, whether that means carrying out additional photostability testing in the midsummer months or adjusting packaging to minimize the ingress of atmospheric moisture on intercontinental shipments.
Every few months, we evaluate shipment temperature logs, reviewing data collected from shipments that crossed hot climates, and discuss real-world degradation scenarios, not just theoretical ones. By updating packaging and storage recommendations, we've prevented issues like aggregation which often show up in material that sits too long at a port or customs warehouse. These precautions help our customers avoid last-minute headaches during incoming inspection or at batch record review.
Years of partnering with pharmaceutical developers and R&D scientists have shown that a dialogue between the manufacturing floor and the formulation lab creates stronger products. Our plant hosts annual reviews with key buyers to discuss sample performance, complaints, and new regulatory needs. One such meeting led to a reformulation of a packaging insert after clients in tropical regions asked for more humidity protection. It’s easy to treat each order as a transaction, but our history tells us that walking production lines with our partners, reviewing process parameters, and sitting in during their validation runs have led to fewer surprises and better-performing products.
Several collaborations began with requests for micro-lot samples to trial new eyedrop formulations. Later, these partners came back for process-scale quantities, requesting minor adjustments in crystal habit or packaging size. Our job, as we see it, is to serve as both manufacturer and technical ally, troubleshooting during pilot scale-up, reviewing impurity retention times, and offering insight based on the cumulative experience from hundreds of commercial scale batches.
Each year brings new scrutiny and shifting requirements in regulated markets like the US, EU, and certain Asian jurisdictions. Our regulatory team receives regular audits not only on documentation but also on minute details of process validation and cleaning procedure qualifications. This attention to compliance provides buyers confidence that each delivery matches stated specifications, but it also challenges us to innovate beyond basic requirements. By investing in additional stability studies, not just during launch but for ongoing commercial production, our Ketotifenum remains a reliable ingredient for customers submitting dossiers in strict approval environments. We've seen that proactive compliance, by investing in human oversight and documentation, avoids delays and supports global supply continuity even in years when shipping or trade regulations change.
As manufacturing partners, we regularly field questions from formulation chemists about residual solvents, impurity spikes, and optimal handling for increasingly complex dosage forms. Sometimes, it means working alongside teams developing slow-release systems. Other times, the focus lies with stability in multi-dose dropper vials. These daily questions shape our technical support. Recently, a client encountered a filtration problem due to an unexpected shift in their process water chemistry. After analyzing retained samples and comparing impurity traces, we identified microcontaminants not present in source Ketotifenum, traced instead to their local water source. Such partnerships turn what might begin as a simple supplier relationship into a longer-term technical support channel.
Continuous process improvement also plays a role as technology evolves. In the past, particle size reduction relied largely on jet milling, but our team has developed methods using controlled crystallization. This approach has shaved several percentage points off of lot-to-lot variability and sparked innovation in filterability and suspensibility for finished products. Bringing in automation on our packaging lines, tied with enhanced environmental monitoring, prevents quality lapses from simple human error or unnoticed environmental drift.
Placing value on long-term relationships over short-term selling cycles has created a customer base that pushes us forward. Whether responding to a regulator's question, assisting with field complaint investigations, or sharing unpublished data from our internal quality programs, the focus stays on transparency and responsiveness. Years of audit experience have shown that no shortcut replaces hands-on oversight or a willingness to adapt process parameters for specific customer use cases. Feedback from our oldest customers points to three themes: consistency, adaptability, and real communication.
We took each lesson learned from past production issues — whether they came from equipment malfunctions, weather-driven shipping delays, or even mid-season impurity profile drift — and invested back into facilities, staff training, and client-facing technical documentation. Today, we share these insights as a practical guide to manufacturers and research chemists who depend on our Ketotifenum for their formulations.
Producing Ketotifenum goes deeper than simple batch output and shipping documentation. Walking the production floor, troubleshooting crystallization challenges, fielding late-night calls about shipment delays, and opening up QC logs to clients facing audit questions — these activities create a team that stands behind every package. The credibility that comes from years of meeting tough customer standards keeps our process dynamic. Feedback — good and bad — finds its way into continuous improvement cycles. Our approach means that formulators, QC managers, and even regulatory reviewers encounter a production partner who listens, adapts, and commits resources where needed.
We know every lot of Ketotifenum carries the reputation of both our company and our partners. The technical stories passed along by client teams, the troubleshooting that happens during scale-up failure, and the incremental process improvements made in response to each round of external audit — all of these shape the final product. In sharing these experiences, we hope to help both new and longstanding partners achieve their quality goals and build resilient supply chains for years to come.